If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
Pharmafocus
March 2012
Vol 14 Issue 3
The Bill that
refused to die
UK government
presses ahead with
unpopular reforms
(p7)
`A China-NICE'?
NICE's chief executive
says emerging markets
want HTA too
(p8)
Rare diseases
Vertex's Kalydeco is
the latest milestone in
rare diseases - but
comes at a price
(p20)
Call for faster pricing in austerity-hit Europe
Brussels says states which exceed agreed timelines could be punished
The European Commission has called
for faster decisions to allow new medi-
cines to enter the market faster.
The Commission says the time taken
for national pricing and reimbursement
of medicines should be made within 120
days for innovative medicines, while
app
Pharmafocus
Success comes more easily when you think big
Pharmafocus March 2012 Pharma in brief Phar
Pharmafocus March 2012 Pharma news AstraZe
Pharmafocus March 2012 Roche's melanoma d
Pharmafocus March 2012 NICE review Zytiga app
Pharmafocus March 2012 UK news NHS reforms
Pharmafocus March 2012 Emerging markets news Em
Pharmafocus March 2012 Major new drugs for 2012
www.icse-usa.com The World's premier Pharma Cont
Galapagos deal could yield Humira successor Abbo
Pharmafocus March 2012 www.inpharm.com/digi
Pharmafocus March 2012 Europe edges clo
Pharmafocus March 2012 Europe's pharma sector :
Pharmafocus March 2012 predecessor, Silv
Pharmafocus March 2012 Doctors, medical educati
Pharmafocus March 2012 a review of 1,574 ar
Pharmafocus March 2012 Manufacturing news I
Pharmafocus March 2012 Marketing news FDA
Pharmafocus March 2012 Rare diseases - pharma's
Pharmafocus March 2012 as a new medicine fo
Pharmafocus March 2012 How leaders kill meanin
Pharmafocus March 2012 act together on exa
InPharm webinar Biosimilars: US, Europe & Beyond
Pharmafocus March 2011 DIA Featured Exhibitor
Pharmafocus March 2012 Careers & Jobs The latest
Pharmafocus March 2012 Meetings, bloody meeting
Pharmafocus March 2012 Working Life Mi
Pharmafocus March 2012 Why strategies fail to
Pharmafocus March 2012 Appointments Dietmar L
Pharmafocus March 2012 Luc Verhels
Pharmafocus March 2012 Publicis buys Chi